Limitations of this study include the inter-sample variation in disease activity based on the in vitro granuloma model and also based on well-established disease phenotypes such as Lӧfgren’s (self-limited disease) and non-Lӧfgren’s (progressive) and related TNFα responses (Lepzien et al., 2021). This evidence concerns the gene TNF and glycogen storage disease VI.